Advertisement

Topics

Funding round pulls in $60M for Prelude

05:58 EDT 13 Jun 2019 | SmartBrief

A round of Series B funding has raised $60 million for Prelude Therapeutics, which intends to use the proceeds to fund clinic -More

Original Article: Funding round pulls in $60M for Prelude

NEXT ARTICLE

More From BioPortfolio on "Funding round pulls in $60M for Prelude"

Advertisement
Quick Search
Advertisement
Advertisement